Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod

Neurology. 2015 Sep 15;85(11):1001-3. doi: 10.1212/WNL.0000000000001929. Epub 2015 Aug 19.

Author

Affiliation

¹ From the Multiple Sclerosis Center, Neurology and Neuroscience Associates, Unity Health Network, Akron, OH. dhuang@nnadoc.com.

PMID: 26291283
DOI: 10.1212/WNL.0000000000001929

No abstract available

Publication types

Case Reports

MeSH terms

Brain / pathology
Cryptococcosis / complications
Cryptococcosis / diagnosis
Cryptococcosis / drug therapy
Cryptococcosis / pathology*
Fingolimod Hydrochloride / administration & dosage
Fingolimod Hydrochloride / therapeutic use*
Flucytosine / therapeutic use*
Humans
Male
Middle Aged
Multiple Sclerosis / complications
Multiple Sclerosis / diagnosis
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / pathology
Skin / pathology
Treatment Outcome

Substances

Flucytosine
Fingolimod Hydrochloride